Sanofi News

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Oct 31 19:00

6-K: 15.7% Sales Growth Boosted by Earlier-Than-Anticipated Vaccine Sales; 2024 Business Eps Guidance Raised Due to Strong Business Performance

Oct 26 00:42

6-K: Sanofi and Orano Join Forces to Develop Next-Generation Radioligand Medicines and Sanofi and CD&R Partner to Fuel Opella's Ambitions in Consumer Healthcare

Oct 21 23:50

6-K: New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infants and Sanofi in discussions to sell a controlling stake in Opella

Oct 12 03:39

6-K: Dupixent Approved in China as the First-Ever Biologic Medicine for Patients with COPD and Dupixent Approved in the US as the First-Ever Biologic Medicine for Patients with COPD

Oct 2 23:09

6-K: Colletion of Recent Announcements

Sep 25 02:57

6-K: Colletion of Recent Announcements

Sep 14 00:51

6-K: Tolebrutinib Meets Primary Endpoint in HERCULES Phase 3 Study, The First and Only to Show Reduction in Disability Accumulation in Non-relapsing Secondary Progressive Multiple Sclerosis

Sep 3 22:51

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-SANOFI(15.80%)

Aug 13 21:12

3: Initial statement of beneficial ownership of securities-10% Owner Sanofi

Aug 13 18:32

6-K: Sarclisa Induction Treatment Demonstrated Significantly Improved Progression-Free Survival in Patients with Newly Diagnosed Multiple Myeloma Eligible for Transplant

Aug 13 18:10

6-K: Sanofi Reports Strong Second Quarter Results with 10% Sales Growth; 2024 Guidance Upgraded

Jul 25 23:48

6-K: 2024 Half-Year Financial Report

Jul 25 22:29

6-K: Dupixent Approved in the EU as the First-Ever Targeted Therapy for Patients with COPD and NEJM Publishes ALTUVIIIO XTEND-Kids Phase 3 Data Supporting Its Potential to Transform the Treatment Landscape for Children with Severe Hemophilia A

Jul 23 23:29

6-K: Colletion of Recent Announcements

Jul 3 02:30

11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)

Jun 29 04:31

11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)

Jun 29 04:23

6-K: Colletion of Recent Announcements

Jun 12 01:58

SC 13G: Statement of acquisition of beneficial ownership by individuals-Sanofi(8.0%)

Jun 1 04:39

6-K: Sanofi Completes Acquisition of Inhibrx, Inc

May 31 04:37